PAXMAN Scalp Cooling Technology Now Available in Canada: A Milestone in Side Effect Management for Cancer Patients Undergoing Chemotherapy

28 March 2024
Paxman scalp cooling device

Paxman, the global leader in scalp cooling technology, is thrilled to announce the availability of its groundbreaking Scalp Cooling System in Canada. This innovative technology marks a significant advancement in the quality of care for cancer patients, offering them a proven solution to effectively manage the side-effect of chemotherapy-induced hair loss. The introduction of the Paxman Scalp Cooling System in Canadian cancer treatment facilities underscores a commitment to improving the well-being and treatment experience of cancer patients across the country [and as a signifier of high-quality cancer care]. 

Chemotherapy-induced alopecia (CIA) is a common side effect of chemotherapy, affecting a vast majority of patients. The psychological impact of hair loss can be profound, with many patients reporting feelings of distress, loss of identity, and decreased self-esteem. The Paxman Scalp Cooling System addresses this issue head-on by significantly reducing the likelihood of hair loss during chemotherapy. 

The Paxman Scalp Cooling System works by reducing the temperature of the scalp immediately before, during, and after the administration of chemotherapy. This process decreases the blood flow to hair follicles, which can reduce the amount of chemotherapy medication that reaches them, minimizing hair loss potentially increasing hair regrowth earlier, and better hair renewal long term. Clinical trials have demonstrated the efficacy and safety of scalp cooling, with a high percentage of patients experiencing a significant reduction in hair loss. 

"We are committed to improving the cancer care journey for patients, and the launch of the Paxman Scalp Cooling System in Canada is a testament to that commitment," said Richard Paxman, CEO of PAXMAN. "We believe that by reducing the side effects associated with chemotherapy, we can make a significant difference in the lives of patients, helping them to maintain their identity and privacy during what is often a difficult time." 

The Paxman Scalp Cooling System is now available in select hospitals and treatment centers across Canada including Princess Margaret, Sunnybrook, Sinai Health Toronto, Markham, and Windsor Regional, and opening soon in Ottawa General and the IGFCC as of April 1st, 2024. Healthcare providers are encouraged to contact Paxman for more information on how they can enable access to this life-enhancing technology for their patients. Additionally, anyone interested in scalp cooling as part of their chemotherapy treatment are advised to consult their healthcare providers or contact Paxman Canada directly at canada@paxmanscalpcooling.com  

For more information about the Paxman Scalp Cooling System, including patient testimonials and substantial clinical data, please visit www.coldcap.com www.scalpcoolingstudies.com  

MDL No. 86975
© Paxman Coolers 2022
Paxman Locations
Changing the face of cancer around the world
Europe
Austria
Belgium
Bulgaria
Cyprus
Czech Republic
France >
Georgia
Germany
Greece
Hungary
Italy
Lithuania
Luxembourg
Malta
Netherlands
Norway
Poland
Portugal
Republic of Ireland
Romania
Russian Federation
Serbia
Slovakia
Slovenia
Spain
Sweden
Switzerland
Turkey
Ukraine
Asia
Armenia
Bangladesh
Hong Kong
India
Indonesia
Japan
Malaysia
Pakistan
Singapore
South Korea
North & South Amercia
Argentina
Brazil
Iraq
Colombia
Dominican Republic
Mexico
Puerto Rico
Uruguay
US Virgin Islands
Venezuela
Middle East
Bahrain
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Qatar
Saudi Arabia
United Arab Emirates
Africa
Morocco
South Africa
Oceania
Australia
New Zealand